[关键词]
[摘要]
目的 观察血必净注射液治疗脑卒中相关性肺炎的临床疗效。方法 将42例患者随机均分为治疗组和对照组,两组均给予常规治疗,治疗组加用血必净注射液50 mL,静脉滴注,每天2次,两组均连续给药7 d。结果 治疗组总有效率为90.5%,明显高于对照组的66.7%(P<0.05)。治疗组体温、呼吸、心率、白细胞计数、C反应蛋白变化较对照组有所改善(P<0.05)。治疗组退热及咳嗽缓解时间均明显少于对照组(P<0.05)。两组均未见明显不良反应。结论 血必净注射液有良好的抗炎作用,在脑卒中相关性肺炎的治疗中有积极辅助作用,且无明显不良反应。
[Key word]
[Abstract]
Abstract:Objective To observe the clinical therapeutic effect of Xuebijing Injection on stroke-associated pneumonia (SAP). Methods A total of 42 patients with SAP were randomly divided into two groups. The patients in the two groups were all given regular treatment. Besides the regular treatment, the patients in the Xuebijing group received iv drip of 50 mL Xuebijing Injection twice a day. The course of the treatment was 7 d. Results The total effective rate in Xuebijing group (90.5%) was significantly higher than that in the control group (66.7%) (P < 0.05). Compared with the control group, the body temperature, respiration, heart rate, white blood cell count, and C-reactive protein of Xuebijing group were obviously improved (P < 0.05). Compared with the control group,the time of defervescence and cough relief in Xuebijing group reduced obviously (P < 0.05). There were no obvious adverse reactions in all patients. Conclusion Xuebijing Injection has the anti-inflammatory effect and it is a positive adjunctive therapy for the treatment of SAP without obvious adverse reactions.
[中图分类号]
[基金项目]